The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFS.L Regulatory News (AFS)

  • There is currently no data for AFS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed transfer of listing to TASE

28 Apr 2021 15:40

RNS Number : 9556W
Amiad Water Systems Ltd
28 April 2021
 

28 April 2021

 

Amiad Water Systems Ltd.

("Amiad" or the "Company")

 

Proposed transfer of listing to TASE

Proposed cancellation of admission of ordinary shares to trading on AIM

Proposed listing of ordinary shares on TASE

 

Amiad (AIM: AFS), a leading global producer of water treatment and filtration solutions, announces the proposed cancellation of the admission of the Company's ordinary shares of NIS 0.5 each ("Ordinary Shares") to trading on AIM (the "AIM Cancellation") and a proposed listing of the Company's Ordinary Shares to trading on the Tel Aviv Stock Exchange ("TASE") (the "TASE Listing"), which remains subject to a number of conditions including shareholder approval.

 

Following a careful review of the benefits and drawbacks of the Company's shares continuing to be admitted to trading on AIM and whether it should seek a listing on an alternative exchange, the board of directors of Amiad (the "Board") has concluded that a TASE Listing and simultaneous AIM Cancellation is likely to be in the best interests of both the Company and its shareholders as a whole. The Board believes that TASE is a more suitable platform for the Company's shares to be listed as it offers access to capital at significantly lower costs, as well as providing exposure to local funds and investors in Israel where the Company's headquarters are located. The Board remains committed to the Company continuing to remain a public company and for the Ordinary Shares to be traded on an internationally recognised stock exchange. It therefore intends to seek shareholder approval for the cancellation of the admission of its Ordinary Shares to trading on AIM conditional upon the TASE Listing becoming effective.

 

The Ordinary Shares will continue to be admitted to trading on AIM prior to the proposed AIM Cancellation and the TASE Listing. If the TASE Listing does not ultimately occur, the Company's Ordinary Shares are expected to continue to trade on AIM for the foreseeable future.

 

Circular and Extraordinary General Meeting

 

The Company intends to post a circular to shareholders (the "Circular") containing a notice to convene an extraordinary general meeting (the "EGM") to seek shareholder approval for the proposed AIM Cancellation conditional upon and simultaneous with the TASE Listing. The Circular will provide further information on the reasons for the proposed TASE Listing and AIM Cancellation, and will provide details of dealing and settlement arrangements.

 

The proposed AIM Cancellation will be conditional, pursuant to Rule 41 of the AIM Rules for Companies (the "AIM Rules"), upon the approval of not less than 75 per cent of the votes cast by shareholders (whether present in person or by proxy) at the EGM.

 

Timetable 

 

Under the AIM Rules, the Company is required to give at least 20 clear Business Days' notice of the proposed AIM Cancellation date. Additionally, the proposed AIM Cancellation will not take effect until at least five clear Business Days have passed following the passing of the proposed resolutions at an EGM to be summoned by the Company for that purpose.

 

The Company's current intention is to issue a circular to shareholders in June that will include a notice convening an EGM to be held in July. Subject to the receipt of the requisite approvals from shareholders and the Israel Securities Authority, the Company currently expects the proposed AIM Cancellation and the TASE Listing to become effective on the same day in early August. However, the Company cannot be certain at this stage as to whether such a timetable will be achievable.

 

Accordingly, the Company will announce definitive dates for the EGM and, ultimately, the TASE Listing and the AIM Cancellation as soon as it is in a position to do so.

 

The Company will update the market in due course.

 

This announcement contains inside information for the purposes of the Market Abuse Regulation (596/2014/EU) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. The person responsible for arranging for the release of this announcement on behalf of the Company is Dori Ivzori, Chief Executive Officer.

 

Enquiries

 

Amiad Water Systems Ltd.

 

Dori Ivzori, Chief Executive Officer

Relly Shimko, Chief Financial Officer

+972 4 690 9500

 

Stifel Nicolaus Europe Ltd.

 

Fred Walsh, Stewart Wallace

+44 20 7710 7600

 

Luther Pendragon

 

Harry Chathli, Claire Norbury

+44 20 7618 9100

  

 

About Amiad

 

Amiad Water Systems (AIM: AFS) is a leading global producer of automatic, self-cleaning water treatment and filtration products and systems. Through its engineering skills and ability to innovate, Amiad provides cost-effective "green" solutions for irrigation and industrial purposes. In these markets, its unique and high-quality products are being integrated into the core of systems for filtration and water treatment, micro irrigation and membrane protection, wastewater and potable water treatment, cooling systems and sea water filtration. Headquartered in Israel, Amiad provides these solutions through ten subsidiaries and a comprehensive network of distributors to customers in more than 80 countries.

 

FIMI Opportunity Funds, the leading private equity investor in Israel, is a controlling shareholder of Amiad, with an interest in 39.5% of the Company's outstanding issued share capital.

 

For additional information or product details, please visit www.amiad.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZVLFLFZLXBBQ
Date   Source Headline
3rd Feb 201711:05 amRNSHolding(s) in Company
30th Jan 20176:21 pmRNSHolding(s) in Company
21st Dec 201612:19 pmRNSTransfer in significant shareholding
3rd Nov 201611:12 amRNSResult of EGM
18th Oct 20163:21 pmRNSDirector/PDMR Shareholding
29th Sep 20167:00 amRNSAppointment of CEO and Notice of EGM
8th Sep 20167:00 amRNSInterim Results
23rd Aug 20164:02 pmRNSBusiness and Trading Update
17th Aug 201611:54 amRNSResult of AGM
13th Jul 201612:00 pmRNSNotice of AGM
7th Jul 20169:35 amRNSHolding(s) in Company
7th Jun 20167:00 amRNSDirectorate Change
24th May 20164:53 pmRNSDirector Shareholding
10th May 20165:00 pmRNSPublication of Annual Report and Accounts
24th Mar 20167:00 amRNSFull Year Results
2nd Feb 20167:00 amRNSBusiness and Trading Update
4th Nov 20157:17 amRNSNetafim sign exclusive distribution agreement
10th Sep 20157:00 amRNSInterim Results
7th Sep 20157:00 amRNSAmiad establishes subsidiary in UK
3rd Sep 20153:44 pmRNSNotice of Interim Results
28th Jul 201511:43 amRNSResult of AGM and Directorate Change
23rd Jun 20155:17 pmRNSNotice of AGM
2nd Jun 20153:05 pmRNSDirector Share Purchase
30th Apr 20155:41 pmRNSAnnual Financial Report
31st Mar 20157:00 amRNSFull Year Results
27th Mar 20157:00 amRNSAppointment of Non-Executive Director
3rd Mar 20157:00 amRNSChange of Nominated Adviser and Broker
25th Feb 20152:23 pmRNSResult of EGM & Non-Executive Director appointment
18th Feb 20157:00 amRNSAmiad receives NSF accreditation
11th Feb 20151:07 pmRNSHolding(s) in Company
11th Feb 20151:01 pmRNSHolding(s) in Company
29th Jan 20155:03 pmRNSGrant of Options
21st Jan 201510:04 amRNSNotice of EGM
17th Dec 20147:00 amRNSAppointment of Chief Financial Officer
5th Dec 20147:00 amRNSDirector/PDMR Shareholding
3rd Dec 20144:09 pmRNSDirector's Share Purchase
25th Nov 20143:07 pmRNSDirector's Shareholding
18th Nov 20147:00 amRNSBusiness and Trading Update
28th Oct 20143:17 pmRNSHolding(s) in Company
28th Oct 20147:00 amRNSManagement Change
2nd Oct 20144:04 pmRNSHolding(s) in Company
22nd Sep 20142:09 pmRNSResult of AGM
11th Sep 20147:00 amRNSResults for the six months to 30 June 2014
18th Aug 20144:52 pmRNSNotice of AGM
21st Jul 20147:00 amRNSBusiness and Trading Update
26th Jun 20145:00 pmRNSPublication of Annual Report and Accounts
23rd Apr 20147:00 amRNSDirectorate Change
2nd Apr 20147:00 amRNSResults for the twelve months to 31 December 2013
31st Mar 20147:00 amRNSAppointment of Non-Executive Director
24th Mar 20147:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.